MedPath

Istinye University

Istinye University logo
🇹🇷Turkey
Ownership
Private
Established
2015-01-01
Employees
501
Market Cap
-
Website
https://www.istinye.edu.tr

Clinical Trials

111

Active:4
Completed:51

Trial Phases

1 Phases

Not Applicable:71

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (71 trials with phase data)• Click on a phase to view related trials

Not Applicable
71 (100.0%)

Disease Severity, Mortality Risk, and Muscle Function in Intensive Care Unit Patients

Recruiting
Conditions
Critically Ill Patients
First Posted Date
2025-08-15
Last Posted Date
2025-08-15
Lead Sponsor
Istinye University
Target Recruit Count
45
Registration Number
NCT07124442
Locations
🇹🇷

Istinye University Bahçeşehir Liv University Hospital, Istanbul, Esenyurt, Turkey

Respiratory Muscle Strength, Endurance, and Postural Control in Chronic Neck Pain With Disability

Completed
Conditions
Neck Pain Chronic
Respiratory Function
First Posted Date
2025-08-15
Last Posted Date
2025-08-15
Lead Sponsor
Istinye University
Target Recruit Count
60
Registration Number
NCT07124455
Locations
🇹🇷

Istinye University, Istanbul, Zeytinburnu, Turkey

Hyperventilation and Physical Performance in Obesity

Recruiting
Conditions
Obesity
First Posted Date
2025-08-14
Last Posted Date
2025-08-14
Lead Sponsor
Istinye University
Target Recruit Count
30
Registration Number
NCT07122804
Locations
🇹🇷

Istinye University, Istanbul, Turkey

Emotional Suppression in Elderly Individuals

Recruiting
Conditions
Elderly Person
First Posted Date
2025-08-14
Last Posted Date
2025-08-17
Lead Sponsor
Istinye University
Target Recruit Count
50
Registration Number
NCT07122817
Locations
🇹🇷

Istinye University, Istanbul, Turkey

Dysfunctional Breathing and Physical Fitness in Older Adults

Recruiting
Conditions
Dysfunctional Breathing
Older Adults
First Posted Date
2025-08-06
Last Posted Date
2025-08-06
Lead Sponsor
Istinye University
Target Recruit Count
120
Registration Number
NCT07107191
Locations
🇹🇷

Yunus Emre TÜTÜNEKEN, Istanbul, Zeytinburnu, Turkey

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 23
  • Next

News

Liv Hospital Partners with University of Pennsylvania to Establish Local CAR-T Cell Manufacturing in Turkey

Liv Hospital and Istinye University have signed a comprehensive collaboration with the University of Pennsylvania's Perelman School of Medicine to develop CAR-T cell therapy and proton therapy capabilities in Turkey.

Cemiplimab Shows Significant Survival Benefit in NSCLC Patients with Brain Metastases and High PD-L1 Expression

First-line cemiplimab (Libtayo) monotherapy demonstrated a remarkable survival advantage over chemotherapy in advanced NSCLC patients with PD-L1 ≥50% and brain metastases, with median OS of 52.4 vs 20.7 months.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.